Seeking Alpha

Ginkgo Bioworks and Centrient Pharmaceuticals Announce Expansion of Partnership Following Success of Initial Project to Bring Sustainable Innovation to the Generic API Space

RIJSWIJK, Netherlands and BOSTON, May 25, 2023 /PRNewswire/ -- Centrient Pharmaceuticals ("Centrient"), the global business-to-business leader in sustainable antibiotics, next-generation statins and ...
Houston Chronicle

Should You Add Ginkgo Bioworks Holdings to Your Biotech Portfolio?

Ginkgo Bioworks (DNA) went public last September through an SPAC deal with Soaring Eagle Acquisition Corporation, a blank-check company led by former MGM CEO Harry Sloan. However, the stock has ...
Nasdaq

If You Invested $1,000 in Ginkgo Bioworks in 2021, This Is How Much You Would Have Today

Ginkgo Bioworks (NYSE: DNA) went public a few years ago. With sky-high expectations for growth spanning multiple industries, it may have been tempting for investors to take a chance on the ...
Law

Ginkgo Bioworks Faces Securities Litigation After Going Public Via SPAC Merger

Biotech company Ginkgo Bioworks, which went public via SPAC merger with Soaring Eagle, and members of its board of directors were hit with a shareholder derivative lawsuit on Friday in California ...
Seeking Alpha

Ginkgo Bioworks: More Revenue Issues

Ginkgo Bioworks' Q3 results reveal uncertainty in its near-term future, with a disappointing performance in its Cell Engineering segment. The company's revenue has been heavily reliant on its ...